The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.

Samoilovich, E O; Kapustik, L A; Feldman, E V; Yermolovich, M A; Svirchevskaya, A J; Zakharenko, D F; Fletcher, M A; Titov, L P

Samoilovich, E O; Kapustik, L A; Feldman, E V; Yermolovich, M A; Svirchevskaya, A J; Zakharenko, D F; Fletcher, M A; Titov, L P.

Affiliation

Samoilovich EO; Research Institute for Epidemiology and Microbiology, Public Health Ministry of the Republic of Belarus, Minsk, Belarus.

Cent Eur J Public Health ; 8(3): 160-3, 2000 Aug.

Article de En | MEDLINE | ID: mdl-10965439

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rubéole / Vaccin contre la rougeole, les oreillons et la rubéole / Rougeole / Oreillons Type d'étude: Clinical_trials Limites: Humans / Infant Pays/Région comme sujet: Europa Langue: En Journal: Cent Eur J Public Health Sujet du journal: EPIDEMIOLOGIA / SAUDE PUBLICA Année: 2000 Type de document: Article Pays d'affiliation: Byelarus Pays de publication: République tchèque

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links